Iam: Good point.
OM.
From the patent looks like you can get away with 100mg a day, should be enough
Example 1: Riboflavin intervention trial. A human intervention study was performed to investigate the effect of riboflavin on the numbers of Faecalibacterium prausnitzii in the gut. A group of 8 volunteers (body weight 60 to 90 kg) were asked to take 1 oral dose of 100 mg riboflavin supplement per day for 14 days.
Two samples were taken in a period of two weeks before the intake, as baseline samples, two samples (one per week) were taken during the intake and one sample a week after intake. The number of F. prausnitzii and that of other bacterial groups were determined by FISH with a specific probes as describe before (Harmsen et al. Appl Environ Microbiol. 2002 Jun; 68(6):2982-90). The numbers of faecalibacteria of the samples taken before and during the intake were averaged and all samples were plotted in Figure 1. The results show that in all volunteers tested, except for individual 7, the number of faecalibacteria increased during intake and decreased again when the intake ceases.
The number of F. prausnitzii also increased relatively to the other bacteria in the feces. The percentage F. prausnitzii increased in 7 out of 8 samples upon riboflavin intake. Other groups of bacteria, such as the butyrate producing Clostridium group XlVa did not increase (Fig. 2). The ratio faecalibacteria/CZosindiwm group XlVa, calculated from before and from during intake, increased in all cases, showing a relative increase of faecalibacteria. Also, the numbers of two potentially pathogenic bacteria were counted, such as Enterobacteriaceae, E. coli-like bacteria of which E. coli is the most abundant in the gut, and Enterococci. This last group was only detected in very low numbers that did not increase during the intervention. The number of E. coli showed much variation among the samples (Fig. 3). However, the number decreased or remained the same during riboflavin intake in all individuals tested. In addition, an inverse relation was detected between the numbers of faecalibacteria and E. coli- like bacteria (Fig 3, lower panel). When E. coli was high, the number of faecalibacteria was relatively low. This situation improved i.e. the ratio shifted towards faecalibacteria, upon administration of riboflavin.
there also might be a tie in with the vinegar thread F. prausnitzii is an acetate consumer
www.nature.com/ismej/journal/v6/n8/full/ismej20125a.html#bib25Post Edited (Old Mike) : 4/30/2016 6:43:05 AM (GMT-6)